Login or Register to make a submission.

The Philippine Journal of Orthopaedics (PJO) accepts manuscripts relevant to orthopaedic surgery, musculoskeletal health, trauma, rehabilitation, and related clinical, surgical, educational, and research disciplines. Authors should select the article type that best reflects the purpose, design, and scope of their submission.

The Editorial Board reserves the right to determine the appropriate article classification and to recommend revisions to meet the journal's editorial and scientific standards.

1. Submissions and Required Documents

1.1 Online Submission

PJO accepts submissions only through its online portal (https://philjorthopaedics.org/index.php/pjo/about/submissions). Hard copies will not be accepted.

Each submission must include (1) the manuscript, (2) the cover letter, (3) the Author Form, and (4) other relevant forms, such as the Informed Consent Form. Submissions are screened for completeness and correctness before review by the editors.

1.2 Cover Letter

A cover letter addressed to the Editor-in-Chief should state the complete title of the work, the final list of all authors, and the intention to submit.

The corresponding author and his or her complete contact information (institutional mailing address, work telephone number, and work e-mail address) should be clearly indicated.

Any previous presentation of the study findings as an abstract or poster at a conference should be mentioned in the letter, including the title and dates of the conference and any awards received.

1.3 Author Form

The Author Form includes the following:

  • Authorship certification: Certification that all listed authors fulfill the authorship criteria.
  • Ethics declaration: Declaration of conformity to publication ethics and to ethical standards for experiments on human or animal subjects, with approval by the appropriate ethics committee.
  • Author Publishing Agreement
  • Author Contribution Disclosure: A list of the specific contributions of each author.
  • Conflict of interest disclosure: Disclosure of any existing conflicts of interest.

The complete name of each author (first name, middle initial, last name), with the title indicating his or her highest educational or professional attainment (e.g., MD, MSc, PhD), and the name and location of not more than one institutional affiliation should be indicated.

1.4 Informed Consent Form

For Case Reports and Case Series, authors must submit a scanned copy of the written informed consent for publication obtained from the patient or subject involved.

PJO requires the use of its standard Informed Consent Form, duly accomplished and submitted with the other requirements.

If the subject(s) and/or the relative or guardian can no longer be contacted after all possible means have been undertaken, the author should state this in the cover letter and describe all efforts made to secure consent.

2. Article Types and Manuscript Requirements

2.1 Original Articles

Original Articles report original clinical, epidemiological, laboratory, biomechanical, surgical, or health services research that contributes new knowledge to orthopaedics and musculoskeletal health.

The manuscript should follow the Introduction, Methods, Results, and Discussion (IMRAD) format.

  • Abstract: Structured, maximum 500 words.
  • Required headings: Objectives, Methodology, Results, and Conclusions.
  • Main manuscript: Maximum 6,000 words, including tables, figures, illustrations, and references.
  • Keywords: At least five Medical Subject Headings (MeSH) terms.

2.2 Review Articles and Systematic Reviews

Review Articles provide a critical synthesis of published evidence relevant to orthopaedic practice, research, education, or policy. Systematic reviews and meta-analyses must describe their search strategy, eligibility criteria, methods of evidence appraisal, and synthesis of findings, as applicable.

  • Abstract: Structured, maximum 500 words.
  • Required headings: Objectives, Methodology, Results, and Conclusions.
  • Main manuscript: Maximum 4,000 words, including tables, figures, illustrations, and references.
  • Keywords: At least five MeSH terms.
  • Reporting guideline: Authors should follow the applicable EQUATOR Network reporting guideline, such as PRISMA for systematic reviews and meta-analyses.

2.3 Case Reports and Case Series

Case Reports describe clinically significant or educationally valuable cases that provide insights into diagnosis, treatment, complications, unusual presentations, or clinical decision-making. Case Series describe a group of patients with a relevant clinical characteristic, condition, or intervention.

  • Abstract: Unstructured, maximum 300 words.
  • Main manuscript: Maximum 3,000 words, including tables, figures, illustrations, and references.
  • Keywords: At least five MeSH terms.
  • Required considerations: Include the relevant clinical history, diagnostic assessment, intervention, outcomes, and clinical lessons. Written informed consent for publication must be obtained and submitted in accordance with PJO requirements.

2.4 Brief Communications

Brief Communications present preliminary but meaningful research findings, concise clinical investigations, technical innovations, or findings that may influence orthopaedic practice. They may also extend or clarify previously published research.

  • Abstract: Unstructured, maximum 250 words.
  • Main manuscript: Maximum 1,500 words, including tables, figures, illustrations, and references.
  • Keywords: At least five MeSH terms.

2.5 Feature Articles

Feature Articles discuss important developments, innovations, educational issues, professional concerns, or emerging perspectives in orthopaedics. They may include invited contributions and scholarly discussions that do not fit the conventional research-article format.

  • Abstract: Unstructured, maximum 300 words.
  • Main manuscript: Maximum 6,000 words, including tables, figures, illustrations, and references.
  • Keywords: At least five MeSH terms.

2.6 Editorials

Editorials provide authoritative commentary on significant developments, current issues, published research, or policy matters relevant to orthopaedics. These are generally commissioned by, or submitted with the prior agreement of, the Editor-in-Chief.

  • Abstract: Not required.
  • Main manuscript: Maximum 1,500 words, excluding references.
  • Keywords: Not required.
  • References: Should be limited to the most relevant sources.

2.7 Letters to the Editor

Letters to the Editor provide constructive commentary on articles published in PJO, raise pertinent scientific or clinical issues, or contribute concise observations relevant to orthopaedic practice.

  • Abstract: Not required.
  • Main manuscript: Maximum 500 words, excluding references.
  • Keywords: Not required.
  • Letters should identify the article being discussed, when applicable, and maintain a scholarly and professional tone.

2.8 Special Announcements

Special Announcements may include information about upcoming orthopaedic conventions, conferences, seminars, professional activities, and other announcements relevant to the journal's readership.

  • Abstract: Not required.
  • Word limit: Determined by the Editorial Board according to the nature of the announcement.
  • Acceptance: Subject to editorial assessment and available publication space. Authors or organizers should coordinate with the Editorial Coordinator.

Editorial discretion: The Editor-in-Chief may consider exceptions to word limits or article classification for submissions of exceptional scientific, clinical, or educational importance. Such exceptions must be approved before or during editorial assessment and do not guarantee acceptance.

3. Title Page

The title page should include the following:

  • Title: The complete title of the article, which should be informative, concise, meaningful, and as brief as possible (no more than 20 words).
  • Authors: The name of each author with his or her highest academic degree(s) and the complete address of one institutional affiliation.
  • Presentations: Any meeting(s) or conference(s) where the material is under consideration for presentation, has been previously presented, and/or has received an award, indicating the title, place, month, and year of the meeting or conference.
  • Corresponding author: The name, mailing address, telephone number, and e-mail address of the corresponding author, who will be responsible for all questions about the manuscript. Only one author should be designated as corresponding author, and he or she need not be the first author.
  • Footnotes: Footnotes for explanatory purposes or additional information may be included, with proper cross-referencing to the main text, using the symbols *, **, and *** in order of use.
  • Financial support: Any financial support, including the agency name and city, company name and city, fellowship name, and/or grant number.

4. Abstract Preparation

4.1 Structured Abstracts

Structured abstracts are required for Original Articles, Review Articles, and Systematic Reviews. Authors should use the following headings:

  • Objectives: State the primary purpose or research question.
  • Methodology: Describe the study design, setting, participants or data sources, interventions or exposures, outcome measures, and principal analytical methods, as applicable. Additional modifiers may be stated (e.g., consecutive, non-consecutive, retrospective, prospective, observational, or interventional).
  • Results: Present the principal findings, including relevant numerical data, effect estimates, confidence intervals, and exact p-values where appropriate.
  • Conclusions: State the principal conclusions and their implications, ensuring that they are directly supported by the findings.

4.2 Unstructured Abstracts

Unstructured abstracts are required for Case Reports, Case Series, Brief Communications, and Feature Articles. They should present a concise narrative summary without section headings.

Depending on the article type, the abstract should summarize the purpose or clinical context, the principal methods or case presentation, the key findings, and the main conclusion or clinical relevance.

4.3 Abstract and Word Count Rules

The abstract must be submitted as part of the manuscript and must comply with the applicable limit for the selected article type. Unless otherwise specified, the abstract, keywords, and main manuscript should be clearly identifiable as separate sections.

The manuscript word limits stated above include tables, figures, illustrations, and references where indicated. Authors should not assume that supplementary materials are exempt from editorial assessment. The Editorial Board may require shortening or restructuring of manuscripts that exceed the applicable limits.

5. Keywords

Authors must provide at least five keywords immediately after the abstract, except for article types for which an abstract and keywords are not required. Keywords should be selected from the Medical Subject Headings (MeSH) database of the US National Library of Medicine (https://www.ncbi.nlm.nih.gov/mesh/) whenever suitable terms are available.

6. Body of the Text

The manuscript should be written in IMRAD format (Introduction, Methodology, Results, and Discussion), followed by the Conclusion(s). Organize and prepare the manuscript to include the sections described below.

6.1 Introduction

The Introduction should refer only to the most pertinent past publications and should not be an extensive review of the literature. Include a brief background, the research question and/or rationale, the objectives or purposes of the study, and the major hypothesis to be tested, if any.

6.2 Methodology

Methods should be written in sufficient detail to permit others to duplicate the work. Include the following, as applicable:

  • Study design: State the study design using a phrase such as randomized or nonrandomized clinical trial, case-control study, cross-sectional study, cohort study, case series, case report, systematic review, meta-analysis, review, experimental study, or historical manuscript.
  • Setting: For example, multicenter, institutional, or clinical practice.
  • Participants, patients, or study population: Number of patients, selection procedures, inclusion and exclusion criteria, randomization procedure, and masking.
  • Interventions or observations: The intervention or observation procedure(s).
  • Outcome measures: Main and secondary outcome measure(s).
  • Data and statistical analyses: Include the software used for the computations.

For Original Articles, statements regarding adherence to the Declaration of Helsinki, approval by the Institutional Review Board (IRB) or Ethics Committee, and a description of the informed consent process should be included.

6.3 Results

Results must be concise. Provide demographic data of the study population. Describe outcomes and measurements in an objective sequence with minimal discussion. Data should be accompanied by confidence intervals (usually at the 95% level) and exact p-values or other indications of statistical significance.

6.4 Discussion

The Discussion should be restricted to the significant findings presented. Avoid excessive generalization and undue speculation. Elucidate on (but do not reiterate) the results, respond to other and contradictory literature, identify the limitations or qualifications of the study, and state the conclusions that are directly supported by the data. Give equal emphasis to positive and negative findings, indicate whether and what additional study is required, and conclude with the clinical applications or implications supported by the study.

6.5 Conclusion(s)

The conclusion(s) should be directly supported by the results. Authors should avoid making statements on economic benefits and costs unless the manuscript includes economic data and analyses.

6.6 Citing Sources in the Text

  • Cite only published studies as references.
  • Quote from the entire study, not the abstract.
  • Authors may acknowledge unpublished data or submitted articles within parentheses in the text.
  • Reference to a personal communication within parentheses in the text must be accompanied by a signed permission letter from the individual being cited.

7. Reporting Guidelines

Authors must use appropriate reporting guidelines for their study design. Examples include CONSORT for randomized trials, STROBE for observational studies, PRISMA for systematic reviews and meta-analyses, CARE for case reports, and STARD for diagnostic accuracy studies. Applicable checklists should be submitted when required by the journal.

8. Style and Disclosures

8.1 Abbreviations

Restrict abbreviations to those that are widely used and understood. Avoid abbreviations that have meaning only in the context of the specific manuscript. Spell out each abbreviation the first time it is mentioned in the text, followed by the abbreviation in parentheses.

8.2 Measurements

All measurements and weights should be expressed in SI units.

8.3 Drugs, Instruments, and Equipment

Use only generic drug names in the body of the text. When a particular drug is first mentioned, state its trade name in parentheses, including the manufacturer's name, city, state, and/or country.

For instruments or equipment used in the study, state in parentheses the specific model and the manufacturer's name, city, state, and/or country.

8.4 Conflicts of Interest

Include a statement disclosing any existing conflicts of interest, the source(s) of funding for the study and the manuscript, and acknowledgments to individuals, groups of persons, or institution(s).

8.5 Funding Sources

State the funding source(s) for the study on which the manuscript is based, including the writing of the manuscript.

8.6 Acknowledgments

Contributors to the work who do not fulfill the authorship criteria should be acknowledged.

9. Tables, Figures, and Appendices

9.1 Tables

Tables should follow the references. Each table must be titled and numbered consecutively in Arabic numerals in the order in which it is mentioned in the text. The title should be brief and fully understandable without reference to the text. Each table column and row must have a heading. Tables that report means should include the corresponding standard deviations. Legends must identify all symbols that appear in the tables and graphs. A maximum of five tables may be included in the manuscript.

9.2 Figures (Graphs, Illustrations, and Photographs)

Submit each final figure as an individual Joint Photographic Experts Group (JPEG), Portable Network Graphics (PNG), or Tag Image File Format (TIFF) file with appropriate labels (figure number and title).

Submit the original, raw, and unedited files in the same formats in one folder, labeled to allow comparison with the final figures. Disclose any modifications, such as cropping, changes in color or orientation, or placement of arrows or shapes.

Photographs (clinical photographs, fluorescein angiograms, computed tomography [CT] scans, magnetic resonance imaging [MRI], X-rays, photomicrographs, transmission/scanning electron micrographs [TEM/SEM], graphs, etc.) should have a resolution of at least 600 dpi.

Graphs may be submitted in PowerPoint or Excel format. Text in figures must not be smaller than 10 points when reproduced in the journal. Illustrations must be professionally rendered with appropriate labels. The Editorial Board may request raw data to verify computations.

Number each figure consecutively in Arabic numerals in the order of citation in the text. Each figure should have a brief explanatory legend that identifies all symbols or letters appearing on it. Histologic figures, stains, and magnifications should be noted in the legend.

Graphs that report means should include standard deviations. Clinical photographs should be masked when possible to prevent identification of the patient. Photographs may be submitted in black and white or in full color.

Any figure that has been published elsewhere or adapted should acknowledge the original source, and a release to publish the figure signed by the copyright holder must be submitted.

A maximum of five items per figure type may be included.

9.3 Appendices

Appendices should be used sparingly. They are appropriate for survey forms, lists of the members of a study group, or explanations of complex formulas or information. In studies involving a study group, the writing group authors should be listed with the group name on the title page, and the other group members should be listed in an appendix.

10. References

List only references that are pertinent to the manuscript. Number references consecutively in the text and in the reference list. In the text, reference numbers are entered as superscripts. Authors must verify all references against the original documents; PubMed (http://www.ncbi.nlm.nih.gov) offers a useful reference checker.

References should include the following elements:

  • Journal articles: The author or authors (for more than six authors, list only the first three followed by “et al.”), title, journal name (as abbreviated in Index Medicus), year, volume number, and inclusive page numbers.
  • Books: The author or authors, chapter title (if any), editor or editors (if any), book title, edition (other than the first), city of publication, publisher, copyright year, and inclusive pages of the chapter or section cited.
  • Websites: The author (or website owner), title of the article, date the article was posted, publication (if applicable), complete website address, and date accessed.

For complete sample references, please refer to http://www.nlm.gov/bsd/uniform_requirements.html.

11. Data Sharing and Availability Statement

PJO requires authors to include a data availability statement in the manuscript submission to ensure transparency and uphold scientific integrity.

Authors may select one of the following standard data availability and sharing statements based on the nature of their study:

  • The datasets generated and analyzed in this study are included in the published article.
  • No datasets were generated or analyzed for this research.
  • The datasets for this study are publicly accessible in data repositories (identify the institutional or third-party repository).
  • The datasets are not publicly available because participants did not provide written consent for their data to be shared.
  • The datasets analyzed in this study are held under license and are not available for public sharing.
  • Others (please specify).

Note: Deposited datasets should have a persistent identifier (e.g., a Digital Object Identifier [DOI] or accession number) and should be made publicly available under a license (at minimum, CC BY 4.0).